Eagle Asset Management’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-25,957	Closed	-$117K	–	561
2023 Q4	$117K	Buy	25,957 +4,367	+20%	+$16.2K	﹤0.01%	548
2023 Q3	$77.3K	Hold	21,590	–	–	﹤0.01%	530
2023 Q2	$79.7K	Buy	21,590 +2,217	+11%	+$8.22K	﹤0.01%	526
2023 Q1	$64K	Buy	19,373 +6,544	+51%	+$22.6K	﹤0.01%	537
2022 Q4	$49K	Buy	+12,829	New	+$39.6K	﹤0.01%	528
2022 Q3	–	Sell	-28,833	Closed	-$57K	–	545
2022 Q2	$57K	Hold	28,833	–	–	﹤0.01%	552
2022 Q1	$52K	Buy	28,833 +10,281	+55%	+$16K	﹤0.01%	572
2021 Q4	$24K	Hold	18,552	–	–	﹤0.01%	596
2021 Q3	$20K	Hold	18,552	–	–	﹤0.01%	590
2021 Q2	$29K	Hold	18,552	–	–	﹤0.01%	597
2021 Q1	$33K	Buy	18,552 +2,310	+14%	+$5.29K	﹤0.01%	591
2020 Q4	$31K	Buy	16,242 +5,790	+55%	+$12.2K	﹤0.01%	551
2020 Q3	$22K	Buy	+10,452	New	+$28.7K	﹤0.01%	567